AXSM R&D to Revenue
Axsome Therapeutics Inc · R&D to Revenue
AXSM R&D to Revenue
Latest reported28.70%period ending
AXSM FY R&D/Revenue (0.00% → 28.70%)
Latest values, visible window
High-resolution chart · PNG
AXSM r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 28.7048% | |
| 48.5041% | |
| 36.1951% | |
| 115.8083% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |